What Anxiety Meds Don’t Cause Weight Gain?

Several widely prescribed anxiety medications carry little to no risk of weight gain, and a few are actually linked to modest weight loss. A large 2025 network meta-analysis comparing 27 antidepressants found that many of the drugs commonly used for anxiety disorders, including fluoxetine, sertraline, venlafaxine, and duloxetine, were associated with weight loss relative to placebo rather than gain. Buspirone, the one medication designed purely for generalized anxiety, also appears weight-friendly. But the picture shifts depending on the drug class, the dose, and how long you take it, so the details matter.

SSRIs and SNRIs With Favorable Weight Profiles

Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors are the backbone of anxiety treatment. They are first-line for generalized anxiety disorder, social anxiety, panic disorder, and obsessive-compulsive disorder. The good news is that many of them do not cause meaningful weight gain and, in clinical trials lasting weeks to months, actually showed slight weight loss compared to placebo.

The Lancet’s 2025 network meta-analysis pooled data from over 44,000 participants across 116 studies and found strong evidence of weight loss relative to placebo for fluoxetine (about 0.8 kg less than placebo), sertraline (about 0.8 kg less), venlafaxine (about 0.7 kg less), duloxetine (about 0.6 kg less), citalopram (about 0.7 kg less), desvenlafaxine (about 0.6 kg less), and levomilnacipran (about 0.8 kg less). Even paroxetine, which has a reputation for causing weight gain among the SSRIs, showed a small weight loss of about 0.35 kg relative to placebo in that pooled analysis.¹

Escitalopram and vortioxetine showed little evidence of weight change in either direction in the same analysis, making them essentially weight-neutral. Vilazodone also fell into this neutral category.¹

There is an important caveat here: these numbers come from trials that typically last eight to twelve weeks. Over longer time frames, the picture can shift. SSRIs as a class tend to show more weight gain after months of use than they do in the initial weeks. One analysis found that escitalopram had the greatest weight gain among SSRIs over six months, at about 0.4 kg, with paroxetine close behind.² Those numbers are small enough that most people would not notice them on a scale, but they do mean the short-term data can be somewhat more optimistic than the long-term reality.

Buspirone, the Dedicated Anxiolytic

Buspirone stands apart from the other options because it was developed specifically for anxiety rather than being an antidepressant repurposed for anxiety disorders. It works on serotonin 1A receptors and has no relationship to benzodiazepines, SSRIs, or antihistamines. It is not sedating, not addictive, and not associated with weight gain in clinical experience.

Animal research has actually suggested buspirone might promote weight loss. A study in spontaneously hypertensive rats found that buspirone reduced body weight and abdominal fat, lowered blood pressure, and improved cholesterol profiles, effects the researchers linked to activation of an energy-producing metabolic pathway.³ Rat studies do not translate directly to humans, but the finding is consistent with the general clinical observation that buspirone does not push weight upward.

The downside of buspirone is that it takes two to four weeks to reach full effect, it only works for generalized anxiety (not panic attacks or social anxiety in most cases), and many patients find it underwhelming compared to SSRIs. But if weight is a priority and your anxiety is the chronic, generalized kind, buspirone is one of the cleanest options available.

Bupropion for Anxiety With Coexisting Depression

Bupropion works on norepinephrine and dopamine rather than serotonin, and it is more likely to cause weight loss than weight gain. A systematic review and meta-analysis confirmed that bupropion is generally well tolerated with very low rates of sexual dysfunction and a tendency toward weight loss rather than gain.⁴ The Lancet network meta-analysis placed bupropion among the drugs showing clear weight loss relative to placebo, at roughly 0.8 kg less.¹

Bupropion comes with a significant asterisk for anxiety, though. It is activating, meaning it can increase energy, restlessness, and sometimes jitteriness. For some people with anxiety, that activation makes things worse, not better. Bupropion is not FDA-approved for any anxiety disorder on its own, and most prescribers use it for anxiety only when it is combined with another medication or when anxiety coexists with depression and the patient has strong reasons to avoid weight gain. It is a good tool to know about, but it is not a straightforward first-line anxiety treatment.

Vortioxetine and Vilazodone

These two newer antidepressants get grouped together because they are both classified as multimodal serotonergic agents, and both have earned reputations for favorable side-effect profiles. Vortioxetine in particular has shown a negligible effect on weight gain in clinical data, along with lower rates of sexual dysfunction than traditional SSRIs.⁵ The Lancet meta-analysis confirmed little evidence of weight change with either drug.¹

Vortioxetine acts on multiple serotonin receptor subtypes simultaneously rather than simply blocking reuptake, which researchers believe explains why it sidesteps some of the metabolic effects of standard SSRIs.⁵ Neither drug is as widely prescribed as sertraline or escitalopram, partly because of cost and partly because they are newer with less long-term track record. But for patients who have already gained weight on another medication and want to switch to something weight-neutral, these are worth discussing with a prescriber.

Benzodiazepines and Weight

Benzodiazepines like lorazepam, clonazepam, and alprazolam are prescribed for short-term anxiety relief, especially for panic attacks and acute anxiety episodes. Their relationship with weight is complicated but generally not a major concern in the way that antidepressants or antipsychotics can be.

Benzodiazepines are not typically listed among weight-gaining medications. Animal research has even shown that benzodiazepine receptor agonists reduced body weight gain in both obese and lean rats.⁶ However, at higher concentrations, clonazepam has shown effects on insulin sensitivity and glucose metabolism in human volunteers, which could theoretically influence metabolic health over time.⁷

In practice, the bigger concerns with benzodiazepines are dependence, tolerance, and withdrawal rather than weight. They are not recommended for long-term use in most anxiety disorders, so the question of chronic weight effects rarely comes up. If you are taking a benzodiazepine short-term while waiting for an SSRI to take effect, weight gain from the benzodiazepine itself is unlikely to be a problem.

Which Anxiety Medications Do Cause Weight Gain

Knowing what to avoid is as useful as knowing what to choose. The medications most consistently linked to weight gain include mirtazapine, tricyclic antidepressants like amitriptyline, and the older tetracyclic drug maprotiline. The Lancet meta-analysis found maprotiline led to roughly 1.8 kg of gain over placebo, amitriptyline about 1.6 kg, and mirtazapine about 0.9 kg. Fluvoxamine and mianserin also showed clear weight gain.¹ With tricyclics, the weight gain is dose-dependent and continues accumulating over time; amitriptyline use has been correlated with continuing weight gain over 24 months.

Low-dose quetiapine, an atypical antipsychotic sometimes prescribed off-label for anxiety, also causes weight gain. A systematic review and meta-analysis found that even at low doses, quetiapine led to significant weight gain and worsening cholesterol, with patients about twice as likely to gain 7% or more of their baseline body weight compared to placebo.⁸ Given that first-line anxiety treatments with far better metabolic profiles exist, the trade-off with quetiapine is hard to justify for most anxiety patients.

Why Some Drugs Cause Gain and Others Don’t

The single strongest predictor of whether an antidepressant or psychiatric medication will cause weight gain is how strongly it blocks the H1 histamine receptor. A meta-regression analysis found that anti-histaminergic activity was the dominant factor: when H1-receptor affinity was included in the statistical model, the apparent effects of other receptors (serotonin 2C, muscarinic M3, adrenergic alpha-1) disappeared.⁹ This explains the pattern in the data nicely. Mirtazapine and the tricyclics are potent antihistamines; fluoxetine, sertraline, and bupropion are not.

The serotonin 2C receptor also plays a role, particularly with antipsychotic medications. Research has shown that blocking this receptor, especially alongside dopamine receptor blockade, contributes to the pronounced weight gain seen with drugs like olanzapine and quetiapine.¹⁰ Buspirone, by contrast, activates serotonin 1A receptors without touching histamine or serotonin 2C receptors, which is part of why it is metabolically clean. If you want a rough rule of thumb: the more sedating a psychiatric drug feels, the more likely it is to have antihistamine properties, and the more likely it is to promote weight gain.

Your Personal Risk Varies More Than You Might Think

Two people can take the same drug at the same dose and have very different weight outcomes. Genetics account for a meaningful portion of this variation. A genome-wide association study identified specific gene regions linked to weight gain during psychiatric treatment, including genes involved in metabolic regulation. Research on people taking citalopram found that those who metabolize the drug slowly (so-called poor or intermediate metabolizers of the CYP2C19 enzyme) gained significantly more weight than fast metabolizers: about 2.6% of body weight at six months versus essentially zero change.¹¹ Separate research confirmed that polygenic risk scores for higher body mass index strongly predict who will gain weight on psychiatric medications, meaning your existing genetic tendency toward weight gain matters.¹²

Beyond genetics, your starting weight and lifestyle patterns influence the outcome. A higher baseline BMI has been associated with greater weight gain during psychiatric treatment, and factors like age and waist circumference also predict who gains more. Behavioral patterns matter too: emotional eating, cravings for processed foods, and a history of weight cycling all correlate with higher rates of obesity and metabolic problems in psychiatric patients.¹¹ None of this means that gaining weight on a medication is your fault, but it does mean that someone with several risk factors should be more deliberate about choosing a weight-neutral option from the start.

What to Do If You’re Already Gaining Weight on Your Current Medication

If your anxiety is well controlled but you’re gaining unwanted weight, there are several evidence-based strategies beyond simply stopping the medication, which risks a relapse.

Switch medications: Moving from a higher-risk drug like mirtazapine to a lower-risk one like sertraline, bupropion, or vortioxetine is the most direct fix. This requires working with your prescriber to taper safely.
Add a counteracting agent: Metformin and GLP-1 receptor agonists (the same class as semaglutide) have evidence for offsetting psychiatric medication-related weight gain. These are increasingly used in clinical practice.
Behavioral interventions: Structured exercise programs and dietary changes can partially offset drug-related weight gain, and a review of expert recommendations emphasizes offering these based on patient preference to optimize motivation.

Clinical guidance also recommends treating early weight gain as a warning sign. If you notice meaningful gain in the first few weeks of a new medication, that pattern often continues or accelerates over time. Catching it early and discussing a switch or addition with your prescriber is more effective than waiting months and trying to reverse a larger gain.¹³

One recommendation that gets overlooked: expert opinion suggests that for mild to moderate anxiety disorders, first-line psychotherapy (such as cognitive behavioral therapy) should be considered before medication when possible, partly because it eliminates metabolic side effects entirely.¹³ That is not always practical, and medications remain essential for many people, but it is a legitimate option that avoids the weight question altogether.

Why Weight Matters for Anxiety Treatment Adherence

The concern about weight gain is not vanity. Patients who experience weight gain on psychiatric medications are more likely to stop taking them, which increases the risk of relapse and worsening symptoms. This creates a frustrating cycle: the anxiety comes back, the patient tries another medication, and the process starts over. Choosing a weight-neutral medication from the outset is not just a cosmetic preference. It is a strategy for staying on treatment long enough for it to work.

Metabolic monitoring should ideally start before treatment begins. Expert recommendations include assessing obesity risk factors and recording baseline metabolic markers (weight, waist circumference, blood sugar, lipids) before starting any psychiatric medication, then checking them regularly during follow-up.¹³ In practice, this does not always happen: many prescribers focus on the psychiatric symptoms and do not weigh patients or check metabolic labs until a problem has already developed. If your provider has not mentioned weight monitoring, it is reasonable to bring it up yourself.

Beta-Blockers and Hydroxyzine, Two Other Options Worth Knowing About

Beta-blockers like propranolol are sometimes used off-label for performance anxiety and situational anxiety. They work by blocking the physical symptoms of the adrenaline response, like a racing heart, shaky hands, and sweating. They do not treat the psychological component of anxiety and are not appropriate for chronic anxiety disorders. Older beta-blockers have been associated with modest weight gain, but newer ones have shown better metabolic profiles. Because beta-blockers are used only occasionally for anxiety and at lower doses than for cardiovascular conditions, weight effects are rarely a practical concern in this context.

Hydroxyzine is an antihistamine prescribed for short-term anxiety. Given what we know about H1-receptor blockade driving weight gain in psychiatric medications, you might expect hydroxyzine to be problematic. In practice, it is usually prescribed as needed rather than daily, and at the doses used for anxiety, clinically significant weight gain is uncommon. However, for people who take it regularly and frequently, the antihistamine mechanism is a reason to keep an eye on things. The distinction between occasional use and daily chronic use matters more with hydroxyzine than with most anxiety medications.